Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

Drug maker Lupin on Monday said it has received approval from the US health regulator to market a generic medication for Human Immunodeficiency Virus. The company has received tentative approval from ...

The drugs include Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets and the company is the exclusive first-to-file for this products ...

Lupin has obtained approval from the USFDA to market a generic form of an HIV medication. The approved drug, equivalent to Symtuza tablets, positions Lupin as the exclusive first-to-file. The tablets ...

Lupin also shared that it has received FDA approval for sacubitril and valsartan tablets, 24 mg/26 mg, 49 mg/51 mg and 97 ...

Lupin is an innovation led Transnational Pharmaceutical Company producing developing and marketing a wide range of branded & generic formulations biotechnology products and active pharmaceutical ...

The main industry in which Lupin Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln. Auditor/Auditors for Lupin Ltd is/are B S R & Co LLP. In the main management, M D Gupta is chairman ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

India's CDMO market set to double by 2028, driven by API strength, cost advantages, and global demand diversification.

The world is currently grappling with what US President Trump will do or undo on the tariffs front. And markets will have to deal with this issue till the politics of one-upmanship is settled. As an ...